Avanti il prossimo

Riproduzione automatica

GRACEcast-084_Lung-Cancer_ALK Inhibition: Science and Early Clinical Experience by Dr. Ben Solomon

6 Visualizzazioni • 07/30/23
Condividere
Incorporare
administrator
administrator
Iscritti
0

http://cancergrace.org/

Dr. Ben Solomon of Peter MacCallum Cancer Centre in Melbourne Australia reviews ALK Inhibition from mechanism of action to activity and side effect profile of crizotinib, newly approved for patients with ALK-positive advanced non-small cell lung cancer.

Mostra di più
0 Commenti sort Ordina per
Commenti su Facebook

Avanti il prossimo

Riproduzione automatica